Cite
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment
MLA
Gabriella Campadelli-Fiume, et al. “Retargeted and Multi-Cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-Tumor Treatment.” Molecular Therapy: Oncolytics, vol. 19, Dec. 2020, pp. 253–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....33e0ff896c974912e12b86497d6ded08&authtype=sso&custid=ns315887.
APA
Gabriella Campadelli-Fiume, Gabriella Cotugno, Irene Garzia, Alfredo Nicosia, Maria De Lucia, Francesca Langone, Emanuele Sasso, Guendalina Froechlich, Chiara Gentile, Biljana Petrovic, Anna Morena D’Alise, Nicola Zambrano, Simona Pepe, Veronica Bignone, Elisa Scarselli, & Linda Nocchi. (2020). Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment. Molecular Therapy: Oncolytics, 19, 253–264.
Chicago
Gabriella Campadelli-Fiume, Gabriella Cotugno, Irene Garzia, Alfredo Nicosia, Maria De Lucia, Francesca Langone, Emanuele Sasso, et al. 2020. “Retargeted and Multi-Cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-Tumor Treatment.” Molecular Therapy: Oncolytics 19 (December): 253–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....33e0ff896c974912e12b86497d6ded08&authtype=sso&custid=ns315887.